Anaconda Pharma
Anaconda Pharma is a biopharmaceutical company focusing on the development of treatments for infections by human papillomavirus (HPV).
Anaconda Pharma has raised €2.9M across 1 funding round from 1 investor, most recently a round in Jul 2010. Based in Paris, France; founded 2007; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€2.9M
€2,916,000
Funding rounds
1
Investors
1
distinct backers
Active since
2010-07
latest 2010-07
Funding by year
EUR raised per yearAnaconda Pharma — funding by year — interactive chart.
Data table
| Anaconda Pharma — funding by year | |
|---|---|
| 2010 | €2.9M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2010-07-01 | Other | €2.9M | Aurinvest | View deal → |
Investors
1Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData